Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide

Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide

US Patent 11786579 · Granted Oct 17, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Injectable presentations, syringes and compositions with sustained and/or contro2025
Injectable presentations, syringes and compositions with sustained and/or contro2025
Injectable presentations, syringes and compositions with sustained and/or contro2025
Injectable presentations, syringes and compositions with sustained and/or contro2025
Injectable presentations, syringes and compositions with sustained and/or contro2025
Syringe-connector device for the separate administration of controlled quantitie2024
Syringe-connector device for the separate administration of controlled quantitie2024
Syringe-connector device for the separate administration of controlled quantitie2024
Sustained release formulations comprising very low molecular weight polymers2017
Sustained release formulations comprising very low molecular weight polymers2017
GLP-1 pharmaceutical compositions2012
Catalytic lactide and glycolide (co)polymerization system2011